You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (34) |
Back to Search
Aspartic acid modified dendrimer-based micelle as a highly potent bone resorption surface-targeting nano-carrier for the efficient treatment of bone metastasis
- At: PSWC2020 (2020)
- Type: Poster
- By: KATSUMI, Hidemasa (Kyoto Pharmaceutical University, Biopharmaceutics, Japan)
- Co-author(s): Hidemasa Katsumi: Biopharmaceutis, Kyoto Pharmaceutical University, Kyoto, Japan
Shugo Yamashita: Biopharmaceutis, Kyoto Pharmaceutical University, Kyoto, Japan
Masaki Morishita: Biopharmaceutis, Kyoto Pharmaceutical University, Kyoto, Japan
Toshiyasu Sakane: Biopharmaceutis, Kyoto Pharmaceutical University, Kyoto, Japan;Pharmaceutical Technology, Kobe Pharmaceutical University, Kobe, Japan
Akira Yamamoto: Biopharmaceutis, Kyoto Pharmaceutical University, Kyoto, Japan - Abstract:
Background
Effective treatment of bone metastasis is challenging, because conventional drugs are hardly distributed to the bone resorption surface.Purpose
The aim of this study is to develop cholesterol-terminated polyethylene glycol (PEG) conjugated aspartic acid (Asp) modified polyamidoamine dendrimer-based micelle (Asp-Micelle) as a highly.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026